There is ample evidence for a significant impact of murine Car activation on hypercholesterolemia and cholesterol homeostasis in various animal models of hypercholesterolemia; however, clinical data are lacking, as there is no known CAR ligand for human therapy. The gene discussed is NR1I3; the disease is Hypercholesterolemia.